Skip to main content
Log in

Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Severe intra-abdominal infection commonly requires intensive care. Mortality is high and is mainly determined by disease-specific characteristics, i.e. setting of infection onset, anatomical barrier disruption, and severity of disease expression. Recent observations revealed that antimicrobial resistance appears equally common in community-acquired and late-onset hospital-acquired infection. This challenges basic principles in anti-infective therapy guidelines, including the paradigm that pathogens involved in community-acquired infection are covered by standard empiric antimicrobial regimens, and second, the concept of nosocomial acquisition as the main driver for resistance involvement. In this study, we report on resistance profiles of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis and Enterococcus faecium in distinct European geographic regions based on an observational cohort study on intra-abdominal infections in intensive care unit (ICU) patients. Resistance against aminopenicillins, fluoroquinolones, and third-generation cephalosporins in E. coli, K. pneumoniae and P. aeruginosa is problematic, as is carbapenem-resistance in the latter pathogen. For E. coli and K. pneumoniae, resistance is mainly an issue in Central Europe, Eastern and South-East Europe, and Southern Europe, while resistance in P. aeruginosa is additionally problematic in Western Europe. Vancomycin-resistance in E. faecalis is of lesser concern but requires vigilance in E. faecium in Central and Eastern and South-East Europe. In the subcohort of patients with secondary peritonitis presenting with either sepsis or septic shock, the appropriateness of empiric antimicrobial therapy was not associated with mortality. In contrast, failure of source control was strongly associated with mortality. The relevance of these new insights for future recommendations regarding empiric antimicrobial therapy in intra-abdominal infections is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005;65:1611–20.

    Article  PubMed  Google Scholar 

  2. Blot S, De Waele JJ, Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs. 2012;72:e17-32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tridente A, Clarke GM, Walden A, McKechnie S, Hutton P, Mills GH, et al. Patients with faecal peritonitis admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Intensive Care Med. 2014;40:202–10.

    Article  PubMed  Google Scholar 

  4. Inui T, Haridas M, Claridge JA, Malangoni MA. Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection. Surgery. 2009;146:654–61 (Discussion 661–2).

    Article  PubMed  Google Scholar 

  5. Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med. 2019;45:1703–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016;11:33–32.

    Article  PubMed  PubMed Central  Google Scholar 

  7. De Pascale G, Carelli S, Vallecoccia MS, Cutuli SL, Taccheri T, Montini L, et al. Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients. J Crit Care. 2019;50:169–76.

    Article  PubMed  Google Scholar 

  8. Tellor B, Skrupky LP, Symons W, High E, Micek ST, Mazuski JE. Inadequate source control and inappropriate antibiotics are key determinants of mortality in patients with intra-abdominal sepsis and associated bacteremia. Surg Infect (Larchmt). 2015;16:785–93.

    Article  Google Scholar 

  9. Zhang J, Yu W-Q, Chen W, Wei T, Wang C-W, Zhang J-Y, et al. Systematic review and meta-analysis of the efficacy of appropriate empiric anti-enterococcal therapy for intra-abdominal infection. Surg Infect (Larchmt). 2021;22:131–43.

    Article  Google Scholar 

  10. Sanders JM, Tessier JM, Sawyer RG, Lipsett PA, Miller PR, Namias N, et al. Inclusion of vancomycin as part of broad-spectrum coverage does not improve outcomes in patients with intra-abdominal infections: a post hoc analysis. Surg Infect (Larchmt). 2016;17:694–9.

    Article  Google Scholar 

  11. Righolt CH, Lagace-Wiens P, Mahmud SM. Prevalence, predictors, and consequences of inappropriate empiric antimicrobial therapy for complicated urinary tract and intra-abdominal infections in Winnipeg hospitals. Diagn Microbiol Infect Dis. 2020;96:114891.

    Article  PubMed  Google Scholar 

  12. Boussion K, Zappella N, Grall N, Ribeiro-Parenti L, Papin G, Montravers P. Epidemiology, clinical relevance and prognosis of staphylococci in hospital-acquired postoperative intra-abdominal infections: an observational study in intensive care unit. Sci Rep. 2021;11:5884–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Blot K, Hammami N, Blot S, Vogelaers D, Lambert M-L. Increasing burden of Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecium in hospital-acquired bloodstream infections (2000–2014): a national dynamic cohort study. Infect Control Hosp Epidemiol. 2019;40:705–9.

    Article  PubMed  Google Scholar 

  14. Dickstein Y, Lellouche J, Amar MBD, Schwartz D, Nutman A, Daitch V, et al. Treatment outcomes of colistin- and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial. Clin Infect Dis. 2019;69:769–76.

    Article  CAS  PubMed  Google Scholar 

  15. Carrara E, Pfeffer I, Zusman O, Leibovici L, Paul M. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis. Int J Antimicrob Agents. 2018;51:548–53.

    Article  CAS  PubMed  Google Scholar 

  16. Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect. 2008;14:5–13.

    Article  CAS  PubMed  Google Scholar 

  17. GiViTI Steering Committee, Bertolini G, Nattino G, Tascini C, Poole D, Viaggi B, et al. Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection. Intensive Care Med. 2018;44:1709–19.

    Article  Google Scholar 

  18. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. http://www.eucast.org. Accessed 14 Mar 2014.

  19. European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases. https://atlas.ecdc.europa.eu/public/index.aspx. Accessed 1 Oct 2020.

  20. Dubinsky-Pertzov B, Temkin E, Harbarth S, Fankhauser-Rodriguez C, Carevic B, Radovanovic I, et al. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and the risk of surgical site infection after colorectal surgery: a prospective cohort study. Clin Infect Dis. 2019;68:1699–704.

    Article  PubMed  Google Scholar 

  21. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197:1079–81.

    Article  PubMed  Google Scholar 

  22. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009;63:785–94.

    Article  CAS  PubMed  Google Scholar 

  23. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531–9.

    Article  CAS  PubMed  Google Scholar 

  24. Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, et al. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med. 2006;34:653–9.

    Article  PubMed  Google Scholar 

  25. Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse J-P, et al. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care. 2010;14:R20.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Vogelaers D, De Bels D, Forêt F, Cran S, Gilbert E, Schoonheydt K, et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates—a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents. 2010;35:375–81.

    Article  CAS  PubMed  Google Scholar 

  27. Augustin P, Dinh AT, Valin N, Desmard M, Crevecoeur MA, Muller-Serieys C, et al. Pseudomonas aeruginosa post-operative peritonitis: clinical features, risk factors, and prognosis. Surg Infect (Larchmt). 2013;14:297–303.

    Article  Google Scholar 

  28. Seguin P, Brianchon C, Launey Y, Laviolle B, Nesseler N, Donnio P-Y, et al. Are enterococci playing a role in postoperative peritonitis in critically ill patients? Eur J Clin Microbiol Infect Dis. 2012;31:1479–85.

    Article  CAS  PubMed  Google Scholar 

  29. Dupont H, Friggeri A, Touzeau J, Airapetian N, Tinturier F, Lobjoie E, et al. Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother. 2011;66:2379–85.

    Article  CAS  PubMed  Google Scholar 

  30. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care. 2007;13:195–9.

    Article  PubMed  Google Scholar 

  31. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006;34:646–52.

    Article  PubMed  Google Scholar 

  32. Solomkin JS. Evaluating evidence and grading recommendations: the SIS/IDSA guidelines for the treatment of complicated intra-abdominal infections. Surg Infect (Larchmt). 2010;11:269–74.

    Article  Google Scholar 

  33. Montravers P, Dufour G, Guglielminotti J, Desmard M, Muller C, Houissa H, et al. Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis. Crit Care. 2015;19:70.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Fernández-Guerrero ML, Herrero L, Bellver M, Gadea I, Roblas RF, de Górgolas M. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med. 2002;252:510–5.

    Article  PubMed  Google Scholar 

  35. Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2002;46:1619–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Harbarth S, Uckay I. Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis. 2004;23:73–7.

    Article  CAS  PubMed  Google Scholar 

  37. European Association of Urology (EAU) Urological Infections Guidelines Panel, Bonkat G, Bartoletti RR, et al. Urological infections. Arnhem (NL): EAU Guidelines Office. 2019. https://uroweb.org/guideline/urological-infections/. Accessed 16 Dec 2020.

  38. Chao Y-S, Farrah K. Fluoroquinolones for the treatment of urinary tract infection: a review of clinical effectiveness, cost-effectiveness, and guidelines. CADTH rapid response report: summary with critical appraisal. Ottawa, ON: CADTH. 2019. https://www.ncbi.nlm.nih.gov/books/NBK543513/?report=reader#!po=99.0196/. Accessed 16 Dec 2020.

  39. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103–20.

    Article  PubMed  Google Scholar 

  40. Jeon JH, Kim K, Han WD, Song SH, Park KU, Rhee JE, et al. Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high. Antimicrob Agents Chemother. 2012;56:3043–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Arcilla MS, Van Hattem JM, Bootsma MCJ, van Genderen PJJ, Goorhuis A, Grobusch MP, et al. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: a cross-sectional study. Travel Med Infect Dis. 2020;33:101547.

    Article  PubMed  Google Scholar 

  42. Armand-Lefèvre L, Ruppé E, Andremont A. ESBL-producing Enterobacteriaceae in travellers: doctors beware. Lancet Infect Dis. 2017;17:8–9.

    Article  PubMed  Google Scholar 

  43. Ruppé E, Armand-Lefèvre L, Estellat C, El-Mniai A, Boussadia Y, Consigny PH, et al. Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill. 2014;19:20768.

    Article  PubMed  Google Scholar 

  44. Bonardi S, Pitino R. Carbapenemase-producing bacteria in food-producing animals, wildlife and environment: a challenge for human health. Ital J Food Saf. 2019;8:7956.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Kaesbohrer A, Bakran-Lebl K, Irrgang A, Fischer J, Kämpf P, Schiffmann A, et al. Diversity in prevalence and characteristics of ESBL/pAmpC producing E. coli in food in Germany. Vet Microbiol. 2019;233:52–60.

    Article  CAS  PubMed  Google Scholar 

  46. Ojer-Usoz E, González D, Vitas AI. Clonal diversity of ESBL-producing Escherichia coli isolated from environmental, human and food samples. Int J Environ Res Public Health. 2017;14:676.

    Article  PubMed Central  Google Scholar 

  47. Rubin JE, Ekanayake S, Fernando C. Carbapenemase-producing organism in food, 2014. Emerg Infect Dis. 2014;20:1264–5.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Zilberberg MD, Nathanson BH, Ditch K, Lawrence K, Olesky M, Shorr AF. Carbapenem treatment and outcomes among patients with culture-positive complicated intra-abdominal infections in US hospitals: a retrospective cohort study. Open Forum Infect Dis. 2019;6:504.

    Article  Google Scholar 

  49. Boyd LB, Atmar RL, Randall GL, Hamill RJ, Steffen D, Zechiedrich L. Increased fluoroquinolone resistance with time in Escherichia coli from > 17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis. 2008;8:4–7.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Golzarri MF, Silva-Sánchez J, Cornejo-Juárez P, Barrios-Camacho H, Chora-Hernández LD, Velázquez-Acosta C, et al. Colonization by fecal extended-spectrum β-lactamase-producing Enterobacteriaceae and surgical site infections in patients with cancer undergoing gastrointestinal and gynecologic surgery. Am J Infect Control. 2019;47:916–21.

    Article  PubMed  Google Scholar 

  51. Montravers P, Blot S, Dimopoulos G, Eckmann C, Eggimann P, Guirao X, et al. Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med. 2016;42:1234–47.

    Article  CAS  PubMed  Google Scholar 

  52. De Waele JJ, Hoste EAJ, Blot SI. Blood stream infections of abdominal origin in the intensive care unit: characteristics and determinants of death. Surg Infect (Larchmt). 2008;9:171–7.

    Article  Google Scholar 

  53. Guilbart M, Zogheib E, Ntouba A, Rebibo L, Régimbeau JM, Mahjoub Y, et al. Compliance with an empirical antimicrobial protocol improves the outcome of complicated intra-abdominal infections: a prospective observational study. Br J Anaesth. 2016;117:66–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Ouyang W, Xue H, Chen Y, Gao W, Li X, Wei J, et al. Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China. Int J Antimicrob Agents. 2016;47:210–6.

    Article  CAS  PubMed  Google Scholar 

  55. Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320:984–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The members for the Abdominal Sepsis Study (‘AbSeS’) Group on behalf of the Trials Group of the European Society of Intensive Care Medicine are: Guy Francois, Sonia Labeau, Koen Blot, Mieke Deschepper, Massimo Antonelli, Jeffrey Lipman, Dirk Vogelaers, Amin Lamrous, Cecilia Pereyra, Fernando Lipovestky, Despoina Koulenti, Jan De Waele, Joao Rezende-Neto, Yenny Cardenas, Tomas Vymazal, Hans Fjeldsoee-Nielsen, Philippe Montravers, Matthias Kott, Arvaniti Kostoula, Yash Javeri, Massimo Girardis, Sharon Einav, Dylan de Lange, Luis Daniel Umezawa Makikado, Adam Mikstacki, José-Artur Paiva, Dana Tomescu, Alexey Gritsan, Bojan Jovanovic, Kumaresh Venkatesan, Tomislav Mirkovic, Emilio Maseda, Yalim Dikmen, Benedict Creagh-Brown, Amin Lamrous, Monica Emmerich, Mariana Canale, Lorena Silvina Dietz, Santiago Ilutovich, John Thomas Sanchez Miñope, Ramona Baldomera Silva, Martin Alexis Montenegro, Patricio Martin, Pablo Saul, Viviana Chediack, Giselle Sutton, Rocio Couce, Carina Balasini, Susana Gonzalez, Florencia Maria Lascar, Emiliano Jorge Descotte, Natalia Soledad Gumiela, Carina Alejandra Pino, Cristian Cesio, Emanuel Valgolio, Eleonora Cunto, Cecilia Dominguez, Fernando Lipovestky, Nydia Funes Nelson, Esteban Martin Abegao, Cecilia Pereyra, Norberto Christian Pozo, Luciana Bianchi, Enrique Correger, Maria Laura Pastorino, Erica Aurora Miyazaki, Norberto Christian Pozo, Nicolas Grubissich, Mariel Garcia, Natalia Bonetto, Noelia Elizabeth Quevedo, Cristina Delia Gomez, Felipe Queti, Luis Gonzalez Estevarena, Ruben Fernandez, Ignacio Santolaya, Norberto Christian Pozo, Sergio Hugo Grangeat, Juan Doglia, Graciela Zakalik, Carlos Pellegrini, Maria Monserrat Lloria, Mercedes Esteban Chacon, Mariela Fumale, Mariela Leguizamon, Irene Beatriz Hidalgo, Roberto Julian Tiranti, Paola Capponi, Agustin Tita, Luis Cardonnet, Lisandro Bettini, Agñel Ramos, Luciano Lovesio, Edith Miriam Miranda, Angelica Beatriz Farfan, Carina Tolosa, Lise Segura, Adelina Bellocchio, Brian Alvarez, Adriana Manzur, Rodolfo Lujan, Natalia Fernandez, Nahuel Scarone, Alan Zazu, Carina Groh, Jason Fletcher, Julie Smith, Raman Azad, Nitin Chavan, Helen Wong, Mark Kol, Lewis Campbell, Despoina Koulenti, Therese Starr, Brigit Roberts, Bradley Wibrow, Timothy Warhurst, Meher Chinthamuneedi, Bernal Buitrago Ferney, Marc Simon, Daniel De Backer, Xavier Wittebole, David De Bels, Vincent Collin, Karolien Dams, Philippe Jorens, Jan De Waele, Jasperina Dubois, Jan Gunst, Lionel Haentjens, Nicolas De Schryver, Thierry Dugernier, Joao Rezende-Neto, Sandro Rizoli, Paul Santillan, Yi Han, Ewelina Biskup, Changjing Qu, Xinyu Li, Tao Yu, Lu Weihua, Daniel Molano-Franco, José Rojas, Juan Mauricio Pardo Oviedo, Dario Pinilla, Yenny Cardenas, Edgar Celis, Mario Arias, Anita Vukovic, Maja Vudrag, Matija Belavic, Josip Zunic, Janja Kuharic, Irena Bozanic Kricka, Ina Filipovic-Grcic, Boris Tomasevic, Melanija Obraz, Bruna Bodulica, Martin Dohnal, Jan Malaska, Milan Kratochvil, Igor Satinsky, Peter Schwarz, Zdenek Kos, Ladislav Blahut, Jan Maca, Marek Protus, Eva Kieslichová, Louise Gramstrup Nielsen, Birgitte Marianne Krogh, Francisco Rivadeneira, Freddy Morales, José Mora, Alexandra Saraguro Orozco, Diego Rolando MorochoTutillo, Nelson Remache Vargas, Estuardo Salgado Yepez, Boris Villamagua, Adel Alsisi, Abdelraouf Fahmy, Hervé Dupont, Sigismond Lasocki, Catherine Paugam-Burtz, Arnaud Foucrier, Alexandru Nica, Geneviève Barjon, Jihad Mallat, Guillaume Marcotte, Marc Leone, Gary Duclos, Philippe Burtin, Philippe Montravers, Enora Atchade, Yazine Mahjoub, Benoît Misset, Jean-François Timsit, Claire Dupuis, Benoît Veber, Matthieu Debarre, Oliver Collange, Julien Pottecher, Stephane Hecketsweiler, Mélanie Fromentin, Antoine Tesnière, Christian Koch, Michael Sander, Matthias Kott, Christian Eckmann, Gunnar Elke, Hermann Wrigge, Philipp Simon, Anthoula Chalkiadaki, Charalampos Tzanidakis, Ioannis Pneumatikos, Eleni Sertaridou, Zafiria Mastora, Ioannis Pantazopoulos, Metaxia Papanikolaou, Theonymfi Papavasilopoulou, John Floros, Virginia Kolonia, George Dimopoulos, Chryssa Diakaki, Michael Rallis, Alexandra Paridou, Alexandros Kalogeromitros, Vasiliki Romanou, Charikleia Nikolaou, Katerina Kounougeri, Evdoxia Tsigou, Vasiliki Psallida, Niki Karampela, Konstantinos Mandragos, Eftychia Kontoudaki, Alexandra Pentheroudaki, Christos Farazi-Chongouki, Agathi Karakosta, Isaac Chouris, Vasiliki Radu, Polychronis Malliotakis, Sofia Kokkini, Eliana Charalambous, Aikaterini Kyritsi, Vasilios Koulouras, Georgios Papathanakos, Eva Nagky, Clairi Lampiri, Fotios Tsimpoukas, Ioannis Sarakatsanos, Panagiotis Georgakopoulos, Ifigeneia Ravani, Athanasios Prekates, Konstantinos Sakellaridis, Christos Christopoulos, Efstratia Vrettou, Konstantinos Stokkos, Anastasia Pentari, Kostoula Arvaniti, Kyriaki Marmanidou, Christina Kydona, Georgios Tsoumaropoulos, Militisa Bitzani, Paschalina Kontou, Antonios Voudouris, Elli-Nikki, Flioni, Elli Antypa, Eleftheria Chasou, Souzana Anisoglou, Eirini Papageorgiou, Theoniki Paraforou, Agoritsa Tsioka, Antigoni Karathanou, Aristeidis Vakalos, Bhagyesh Shah, Chirag Thakkar, Nikhilesh Jain, Mohan Gurjar, Arvind Baronia, Prachee Sathe, Shilpa Kulkarni, Cherish Paul, John Paul, Mansoor Masjedi, Reza Nikandish, Farid Zand, Golnar Sabetian, Ata Mahmoodpoor, Seyed Mohammadreza Hashemian, Miklosh Bala, Romeo Flocco, Sergio Torrente, Vincenzo Pota, Savino Spadaro, Carlo Volta, Massimo Girardis, Giulia Serafini, Sabrina Boraso, Ivo Tiberio, Andrea Cortegiani, Giovanni Misseri, Maria Barbagallo, Davide Nicolotti, Francesco Forfori, Francesco Corradi, Massimo Antonelli, Gennaro De Pascale, Lorella Pelagalli, Luca Brazzi, Ferdinando Giorgio Vittone, Alessandro Russo, Davide Simion, Antonella Cotoia, Gilda Cinnella, Patrick Toppin, Roxanne Johnson-Jackson, Yoshiro Hayashi, Ryohei Yamamoto, Hideto Yasuda, Yuki Kishihara, Junji Shiotsuka, Luis Alejandro Sanchez-Hurtado, Brigitte Tejeda-Huezo, Luis Gorordo, Silvio A Ñamendys-Silva, Francisco J Garcia-Guillen, Manuel Martinez, Erick Romero-Meja, Ever Colorado-Dominguez, Huub van den Oever, Karel Martijn Kalff, Wytze Vermeijden, Alexander Daniel Cornet, Oliver Beck, Nedim Cimic, Tom Dormans, Laura Bormans, Jan Bakker, Ditty Van Duijn, Gerrit Bosman, Piet Vos, Dylan de Lange, Lenneke Haas, Akram Henein, Ariel M Miranda, Luis Daniel Umezawa Makikado, Gonzalo Ernesto Gianella Malca, Abel Arroyo-Sanchez, Agnieszka Misiewska-Kaczur, Frisch Akinyi, Miroslaw Czuczwar, Karolina Luczak, Wiktor Sulkowski, Barbara Tamowicz, Adam Mikstacki, Beata Swit, Bronisław Baranowski, Piotr Smuszkiewicz, Iwona Trojanowska, Stanislaw Rzymski, Mariusz Sawinski, Marta Trosiak, Malgorzata Mikaszewska-Sokolewicz, Ricardo Alves, Dina Leal, Andriy Krystopchuk, Pedro Muguel Hilario Mendonca, Rui Antunes Pereira, Maria Raquel Lopes Marques de Carvalho, Carlos Candeias, Elena Molinos, Amélia Ferreira, Guiomar Castro, José-Artur Paiva, José-Manuel Pereira, Lurdes Santos, Alcina Ferreira, Dulce Pascoalinho, Rosa Ribeiro, Guilherme Domingos, Pedro Gomes, David Nora, Rui Pedro Costa, Anabela Santos, Ahmed Subhy Alsheikhly, Dana Tomescu, Mihai Popescu, Ioana Grigoras, Emilia Patrascanu, Igor Zabolotskikh, Tatiana Musaeva, Alexey Gritsan, Denis Gaigolnik, Vladimir Kulabukhov, Vladislav Belskiy, Nadezhda Zubareva, Maxim Tribulev, Ahmed Abdelsalam, Ayman Aldarsani, Muhammad Al-Khalid, Ghaleb Almekhlafi, Yasser Mandourah, Bojan Jovanovic, Krstina Doklestic, Jelena Velickovic, Dejan Velickovic, Radmilo Jankovic, Anita Vukovic, Svetlana Skoric-Jokic, Dragana Radovanovic, Guy Richards, Ahmad Alli, Maria Del Carmen Cordoba Nielfa, Rafael Sánchez Iniesta, Adela Benítez-Cano Martínez, Carlos Garcia Bernedo, Santiago Alberto Picos Gil, Xavier Nuvials, Jordi Rello, Joseba Gonzalez Garcia, Jose Manuel Garcia Peña, Roberto Jimenez, Luis Herrera, Laura Galarza Barrachina, Ignacio Catalan Monzon, Francisco Javier Redondo, Ruben Villazala, Diego Fernando Matallana Zapata, Isabel Maria Villa Lopez, Gabriel Moreno-Gonzalez, Juan Carlos Lopez-Delgado, Jorge Solera Marin, Purificacion Sanchez-Zamora, Montserrat Vallverdú Vidal, Jesús Flores González, Irene Salinas, Cecilia Hermosa, Emilio Maseda, Fernando Martinez-Sagasti, Sara Domingo-Marín, Johanna Abril Victorino, Raquel Garcia-Alvarez, Pablo López-Arcas Calleja, Maria-Victoria de la Torre-Prados, Pablo Vidal-Cortes, Lorena Del Río-Carbajo, Javier Izura, Victoria Minguez, Josep Trenado Alvarez, Anna Parera Prous, Daniel Paz, Ferran Roche-Campo, Gerardo Aguilar, Javier Belda, Jesus Rico-Feijoo, Cesat Aldecoa, Begoña Zalba-Etayo, Martin Lang, Alexander Dullenkopf, Konlawij Trongtrakul, Anusang Chtsomkasem, Türkay Akbaş, Mustafa Necmettin Unal, Menekse Ozcelik, Ayca Gumus, Atilla Ramazanoglu, Dilek Memis, Inal Mehmet, Yalim Dikmen, Seval Urkmez, Asu Ozgultekin, Oktay Demirkiran, Nesrin Ahu Aslan, Deniz Kizilaslan, Ferda Kahveci, Nurdan Ünlü, Zeynep Ozkan, Callum Kaye, Jan Jansen, Orla O'Neill, Christopher Nutt, Rajeev Jha, Nicolas Hooker, Irina Grecu, Christina Petridou, Murali Shyamsundar, Lia McNamee, John Trinder, Samantha Hagan, Catriona Kelly, Jonathon Silversides, Casiano Barrera Groba, Owen Boyd, Kaushik Bhowmick, Sally Humphreys, Charlotte Summers, Petra Polgarova, Michael Margarson, Justin Dickens, Suzanne Pearson, Elaine Chinery, Noel Hemmings, Sinead O'Kane, Pauline Austin, Stephen Cole, Catherine Plowright, Roberta Box, Christopher Wright, Lorna Young, Ben Creagh-Brown, Laura Montague, Robert Parker, Ben Morton, Marlies Ostermann, Julia Bilinska, Bernd Oliver Rose, Rosie Reece-Anthony, Christine Ryan, Mark Hamilton, Philip Hopkins, Julia Wendon, Giovanni Brescia, Nazia Ijaz, James Wood, Michelle George, Piroska Toth-Tarsoly, Bryan Yates, Maureen Armstrong, Carmen Scott, Christine Boyd, Tamas Szakmany, David Rees, Paul Pulak, Mandy Coggon, Bhaskar Saha, Linda Kent, Bethan Gibson, Julie Camsooksai, Henrik Reschreiter, Pat Morgan, Sivatharshini Sangaralingham, Alastair Lowe, Petr Vondras, Sunil Jamadarkhana, Carina Cruz, Rakesh Bhandary, Peter Hersey, Julie Furneval, Richard Innes, Patricia Doble, Ben Attwood, Penny Parsons, Valerie Page, Xiaobei Zhao, Irina Grecu, Julian Dalton, Mohammed Hegazy, Yasser Awad, Douglas Naylor, Amanda Naylor, Sarah Lee, Sidney Brevard, Noelle Davis

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Stijn Blot.

Ethics declarations

Funding

AbSeS is a Trials Group Study of the European Society of Intensive Care Medicine. The study was supported by a Pfizer investigator-initiated research grant.

Conflict of Interest

SB received research grants from Pfizer. PM served as speaker and advisory board member for Menarini, MSD and Pfizer. DV and AVdB have no conflicts of interest to disclose.

Ethics approval

Approval by established national, regional, or local institutional review boards was expedited and granted. The study is registered at ClinicalTrials.gov (number NCT03270345).

Consent

AbSeS is an observational study. Necessity of written informed consent was determined by the national, regional, or local ethics committee or institutional review board.

Availability of data and materials

Due to the numerous data user agreements in this multicenter study, acess to the data is exclusively grated to the ESICM and the head investigator at Ghent University (SB).

Author contributions

DV contributed to the conception and design of the study, interpretation of the results, drafting some parts of first version of the manuscript, and revision of the full paper for important intellectual content. SB contributed to the conception and design of the study, data management, data analysis and interpretation, drafting some parts of first version of the manuscript, and revision of the full paper for important intellectual content. AVdB contributed to data management, data analysis and interpretation, and revision of the paper for important intellectual content. PM contributed to the conception and design of the study, data acquisition, interpretation of the results, and revision of the paper for important intellectual content. All authors read and approved the final manuscript.

Additional information

The members for the Abdominal Sepsis Study (‘AbSeS’) Group on behalf of the Trials Group of the European Society of Intensive Care Medicine is listed in Acknowledgements section.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 131 kb)

Supplementary file2 (XLSX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vogelaers, D., Blot, S., Van den Berge, A. et al. Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units. Drugs 81, 1065–1078 (2021). https://doi.org/10.1007/s40265-021-01534-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40265-021-01534-w

Navigation